Hims & Hers Advances AI-Powered Personalized Digital Healthcare

The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, is intensifying its use of artificial intelligence (AI), data infrastructure and personalization to power a next-generation healthcare experience. The company’s proprietary technology stack integrates electronic medical records, provider algorithms and real-time analytics to deliver individualized treatment pathways. This system enables adaptive recommendations, precise follow-ups and continuous refinement of care based on patient feedback and outcomes. By combining data-driven intelligence with clinical expertise, Hims & Hers transforms routine healthcare interactions into scalable, tech-enabled experiences that preserve human empathy while enhancing efficiency and accessibility.

Recent developments in 2025 underscore this strategic focus. The appointment of Mo Elshenawy as chief technology officer (CTO) marks a pivotal step toward AI-driven automation and intelligent diagnostics. Under his leadership, HIMS is advancing AI tools that seamlessly connect diagnosis, treatment and delivery — aligning with CEO Andrew Dudum’s vision of standardizing personalized, high-quality care at a global scale. In parallel, Hims & Hers’ $870 million convertible notes offering is designed to accelerate investment in data infrastructure and personalized treatment technologies.

These innovations are now reflected in new launches such as Hims’ personalized oral testosterone program and Hers’ menopause and perimenopause specialty, both of which leverage data-driven care models to tailor treatment to individual needs. By merging machine learning with patient data, Hims & Hers is building an intelligent healthcare ecosystem that enhances precision, affordability and access across its expanding wellness portfolio.

Doximity, Inc. DOCS is deepening its use of AI and data to enhance clinical workflows. Doximity’s AI Scribe automates documentation while maintaining HIPAA compliance, and the 2025 acquisition of Pathway adds one of medicine’s largest structured datasets for precise, evidence-based answers. Together, these technologies personalize physician experiences, improve clinical accuracy and strengthen Doximity’s position as the leading digital platform for U.S. medical professionals. The integration of Pathway’s corpus into Doximity GPT further accelerates real-time, AI-informed decision support at the point of care.

American Well Corporation AMWL, popularly known as Amwell, integrates AI and data analytics within its Converge platform to deliver personalized, efficient hybrid care. Its technology enhances clinical decision-making, automates workflows and adapts treatment pathways in real time for patients across major health systems and payers. In 2025, Amwell expanded AI-driven automation and care personalization, solidifying its role as a data-powered digital backbone for modern, scalable healthcare delivery. Amwell’s AI-enabled tools also support the U.S. Military Health System, improving access, efficiency and continuity of care for millions.